Search Results - "Clinical rheumatology"
-
1
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Published in Clinical rheumatology (01-07-2020)“…COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes only mild symptoms in the majority of the cases, while immunologic…”
Get full text
Journal Article -
2
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
Published in Clinical rheumatology (01-07-2020)“…The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global…”
Get full text
Journal Article -
3
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
Published in Clinical rheumatology (01-09-2020)“…The pathogenesis of Coronavirus disease 2019 (COVID-19) is gradually being comprehended. A high number of thrombotic episodes are reported, along with the…”
Get full text
Journal Article -
4
Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?
Published in Clinical rheumatology (01-05-2022)“…To date, around 60% of the world population has been protected by vaccines against SARS-CoV-2, significantly reducing the devastating effect of the pandemic…”
Get full text
Journal Article -
5
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series
Published in Clinical rheumatology (01-11-2020)“…Introduction Covid-19 infection poses a serious challenge for immune-compromised patients with inflammatory autoimmune systemic diseases. We investigated the…”
Get full text
Journal Article -
6
Vasculitis associated with immune checkpoint inhibitors—a systematic review
Published in Clinical rheumatology (01-09-2018)“…Recent experimental and genetic studies have implicated the role of programmed cell death protein 1 (PD-1), programmed cell death protein-ligand 1 (PDL-1), and…”
Get full text
Journal Article -
7
Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months
Published in Clinical rheumatology (01-01-2022)“…Objective To document the detailed characteristics including severity, type, and locations of rheumatic and musculoskeletal symptoms along with other COVID-19…”
Get full text
Journal Article -
8
Post-COVID-19 arthritis: a case report and literature review
Published in Clinical rheumatology (01-08-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the novel pathogen responsible for the coronavirus disease 19 (COVID-19) outbreak. Researchers…”
Get full text
Journal Article -
9
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis
Published in Clinical rheumatology (01-03-2020)“…To present our preliminary experience with JAK inhibitors in treating patients affected by juvenile idiopathic arthritis (JIA) and associated uveitis. Case…”
Get full text
Journal Article -
10
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study
Published in Clinical rheumatology (01-10-2023)“…Objectives To investigate whether the risk of developing an incident autoimmune disease is increased in patients with prior COVID-19 disease compared to those…”
Get full text
Journal Article -
11
Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology
Published in Clinical rheumatology (01-09-2020)“…In the midst of the COVID-19 pandemic, further understanding of its complications points towards dysregulated immune response as a major component. Systemic…”
Get full text
Journal Article -
12
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia
Published in Clinical rheumatology (01-07-2020)Get full text
Journal Article -
13
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis
Published in Clinical rheumatology (01-11-2021)“…The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs) is an evolving area. A systematic review of Scopus, Web of…”
Get full text
Journal Article -
14
Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India
Published in Clinical rheumatology (01-09-2020)“…The emergent COVID-19 pandemic dictates an urgent switch to teleconsultation. India has high patient to rheumatologist ratio, and patients have limited…”
Get full text
Journal Article -
15
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
Published in Clinical rheumatology (01-09-2020)“…Background Over the month of April, Spain has become the European country with more confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd…”
Get full text
Journal Article -
16
Ankylosing spondylitis risk factors: a systematic literature review
Published in Clinical rheumatology (01-08-2021)“…Radiographic axial spondyloarthritis (also known as ankylosing spondylitis [AS]) is a chronic immune-mediated arthritis characterized by inflammation of the…”
Get full text
Journal Article -
17
Haemophagocytic syndrome and COVID-19
Published in Clinical rheumatology (01-04-2021)“…Primary and secondary haemophagocytic lymphohistiocytosis (HLH) are hyperferritinaemic hyperinflammatory syndromes with a common terminal pathway triggered by…”
Get full text
Journal Article -
18
Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample
Published in Clinical rheumatology (01-09-2018)“…Hyperuricemia is not only a risk factor for gout but also an independent determinant of hypertension, diabetes, and chronic kidney diseases. Although the…”
Get full text
Journal Article -
19
A comprehensive review of rituximab therapy in rheumatoid arthritis patients
Published in Clinical rheumatology (01-11-2019)“…Rituximab (RTX) is an approved treatment for rheumatoid arthritis (RA) patients that do not respond adequately to disease-modifying antirheumatic drugs…”
Get full text
Journal Article -
20
Total joint replacement improves pain, functional quality of life, and health utilities in patients with late-stage knee and hip osteoarthritis for up to 5 years
Published in Clinical rheumatology (01-03-2020)“…Objectives To study and identify the determinants of the impact on pain, function, and quality of life of a prosthetic replacement surgery after 5 years of…”
Get full text
Journal Article Web Resource